Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2023-08-17 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections like 'Notification of Major Holdings', detailing changes in the percentage of voting rights held by specific individuals (Robert Atchinson, Phillip Gross) and associated entities, referencing German Securities Trading Act (WpHG) articles. This directly corresponds to the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes or changes in major shareholdings that trigger voting rights notifications. Although it involves share ownership changes, the primary focus and explicit title point to the voting rights notification aspect, making DVA the most precise fit over MRQ (Major Shareholding Notification) which is broader.
2023-08-17 English
Half-yearly financial report 2023
Interim / Quarterly Report Classification · 1% confidence The document is a 'Half-Year Report' for MorphoSys Group covering the period January to June 2023. It contains detailed interim consolidated financial statements, management discussion and analysis (MD&A), and operational business performance updates. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H2 2023
2023-08-17 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and the nature of instruments held by a major shareholder (Bank of America Corporation) in MorphoSys AG. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. Although the header mentions 'Voting Rights Announcements', the content structure (Sections 1 through 10 detailing holdings) aligns perfectly with the regulatory requirement for major shareholding disclosures.
2023-08-14 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details the acquisition/disposal of shares and instruments, showing the resulting percentage of voting rights held by The Goldman Sachs Group, Inc. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the Major Shareholding Notification (MRQ) category. Although it mentions 'Voting Rights Announcements' in the header, the content is a detailed disclosure of ownership thresholds being crossed, which is the core function of an MRQ filing.
2023-08-14 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in the percentage of voting rights held by JPMorgan Chase & Co. and its subsidiaries, crossing specific thresholds (Section 6 shows the new total position is 6.99%). This type of mandatory disclosure regarding changes in significant share ownership directly corresponds to the definition of Major Shareholding Notification.
2023-08-14 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It reports changes in the percentage of voting rights held by JPMorgan Chase & Co. and its subsidiaries, crossing specific thresholds (e.g., 5.27% direct voting rights). This content directly corresponds to the definition of reporting changes in significant share ownership levels, which aligns best with the Major Shareholding Notification category.
2023-08-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.